{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:36:03Z","timestamp":1773326163698,"version":"3.50.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1003798","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T17:54:38Z","timestamp":1409248478000},"page":"e1003798","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Possible Role of Interleukin-1\u03b2 in Type 2 Diabetes Onset and Implications for Anti-inflammatory Therapy Strategies"],"prefix":"10.1371","volume":"10","author":[{"given":"Gang","family":"Zhao","sequence":"first","affiliation":[]},{"given":"Gitanjali","family":"Dharmadhikari","sequence":"additional","affiliation":[]},{"given":"Kathrin","family":"Maedler","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Meyer-Hermann","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/qjmed\/hcg040","article-title":"Deteriorating beta-cell function in type 2 diabetes: a long-term model","volume":"96","author":"A Bagust","year":"2003","journal-title":"QJM"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2337\/diabetes.53.1.160","article-title":"Mode of Onset of Type 2 Diabetes from Normal or Impaired Glucose Tolerance","volume":"53","author":"E Ferrannini","year":"2004","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes","volume":"53","author":"GC Weir","year":"2004","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/db07-0053","article-title":"Progression to Type 2 Diabetes Characterized by Moderate Then Rapid Glucose Increases","volume":"56","author":"CC Mason","year":"2007","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"AG Tab\u00e1k","year":"2009","journal-title":"The Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus","volume":"58","author":"RA DeFronzo","year":"2009","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","article-title":"Pancreatic beta-cell mass in European subjects with type 2 diabetes","volume":"10","author":"J Rahier","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2010.04.009","article-title":"The stunned beta cell: a brief history","volume":"11","author":"E Ferrannini","year":"2010","journal-title":"Cell Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M","article-title":"Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study","volume":"15","author":"J Levy","year":"1998","journal-title":"Diabetic Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrm2327","article-title":"Molecular and metabolic mechanisms of insulin resistance and [beta]-cell failure in type 2 diabetes","volume":"9","author":"DM Muoio","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","first-page":"1249","article-title":"Diabetes","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (ukpds 49)","volume":"281","author":"RCCC Turner","year":"1999","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-008-0031-0","article-title":"Beta-cell failure in type 2 diabetes mellitus","volume":"8","author":"C Lencioni","year":"2008","journal-title":"Curr Diab Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"K Maedler","year":"2002","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/er.2007-0033","article-title":"Cytokines and beta-cell biology: from concept to clinical translation","volume":"29","author":"MY Donath","year":"2008","journal-title":"Endocr Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"MY Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1210\/jc.2008-0396","article-title":"Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation","volume":"93","author":"M B\u00f6ni-Schnetzler","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db06-1650","article-title":"Increased Number of Islet-Associated Macrophages in Type 2 Diabetes","volume":"56","author":"JA Ehses","year":"2007","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"CM Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes","volume":"32","author":"CM Larsen","year":"2009","journal-title":"Dia Care"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc11-0357","article-title":"Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Na\u00efve Patients With Type 2 Diabetes A randomized clinical trial","volume":"34","author":"MG Ramos-Zavala","year":"2011","journal-title":"Dia Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/jc.2010-2992","article-title":"Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study","volume":"96","author":"EJP Van Asseldonk","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes","volume":"35","author":"C Cavelti-Weder","year":"2012","journal-title":"Dia Care"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1463-1326.2012.01637.x","article-title":"Effect of anti-IL-1\u03b2 antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial","volume":"14","author":"A Rissanen","year":"2012","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2337\/dc12-1835","article-title":"Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1\u03b2 Antibody, in Patients With Type 2 Diabetes","volume":"36","author":"J Sloan-Lancaster","year":"2013","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/485S17a","article-title":"Perspective: Testing failures","volume":"485","author":"T Mandrup-Poulsen","year":"2012","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0305683101","article-title":"Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets","volume":"101","author":"K Maedler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00125-009-1349-0","article-title":"Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival","volume":"52","author":"R Glas","year":"2009","journal-title":"Diabetologia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"C Dinarello","year":"1996","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/db09-1199","article-title":"Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes","volume":"59","author":"M Carstensen","year":"2010","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(08)60736-9","article-title":"Intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"371","author":"R Retnakaran","year":"2008","journal-title":"The Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db05-1430","article-title":"Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets","volume":"55","author":"K Maedler","year":"2006","journal-title":"Diabetes"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/jtbi.2000.2150","article-title":"A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes","volume":"206","author":"B Topp","year":"2000","journal-title":"J Theor Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2337\/diabetes.48.9.1677","article-title":"Onset of type 1 diabetes: a dynamical instability","volume":"48","author":"BFD Blasio","year":"1999","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"E1462","DOI":"10.1152\/ajpendo.90444.2008","article-title":"Mathematical models of diabetes progression","volume":"295","author":"AD Gaetano","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"L Perreault","year":"2012","journal-title":"Lancet"},{"key":"ref37","unstructured":"Bergman RN, Lovejoy JC (1997) The Minimal Model Approach and Determinants of Glucose Tolerance. Louisiana State University Press. 406 p."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2003-38385","article-title":"Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices","volume":"35","author":"DA Garc\u00eda-Est\u00e9vez","year":"2003","journal-title":"Horm Metab Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"J Spranger","year":"2003","journal-title":"Diabetes"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/bioinformatics\/bti799","article-title":"Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology","volume":"22","author":"H Schmidt","year":"2006","journal-title":"Bioinformatics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1074\/jbc.M210581200","article-title":"Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes","volume":"278","author":"DR Laybutt","year":"2003","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI112720","article-title":"Natural history of intrahepatic canine islet cell autografts","volume":"78","author":"R Alejandro","year":"1986","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007890-199807150-00004","article-title":"Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice","volume":"66","author":"K Suzuki","year":"1998","journal-title":"Transplantation"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1152\/ajpendo.00421.2011","article-title":"Evaluation of a mathematical model of diabetes progression against observations in the Diabetes Prevention Program","volume":"303","author":"T Hardy","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1615\/CritRevImmunol.v31.i4.30","article-title":"Mechanisms behind the anti-inflammatory actions of insulin","volume":"31","author":"E Hyun","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2337\/dc08-2335","article-title":"Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia","volume":"32","author":"M Pruski","year":"2009","journal-title":"Diabetes Care"},{"key":"ref47","first-page":"1242","article-title":"Rosuvastatin and Metformin Decrease Inflammation and Oxidative Stress in Patients With Hypertension and Dyslipidemia","volume":"60","author":"A G\u00f3mez-Garc\u00eda","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"M Stumvoll","year":"2005","journal-title":"The Lancet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e43056","DOI":"10.1371\/journal.pone.0043056","article-title":"Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis","volume":"7","author":"Y Kita","year":"2012","journal-title":"PLoS ONE"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MED.0b013e32833bf6dc","article-title":"Role of IL-1\u03b2 in type 2 diabetes","volume":"17","author":"CA Dinarello","year":"2010","journal-title":"Current Opinion in Endocrinology, Diabetes and Obesity"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"SL Masters","year":"2010","journal-title":"Nature Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncpendmet0647","article-title":"The replication of beta cells in normal physiology, in disease and for therapy","volume":"3","author":"PC Butler","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","article-title":"Pancreatic \u03b2 Cell Dedifferentiation as a Mechanism of Diabetic \u03b2 Cell Failure","volume":"150","author":"C Talchai","year":"2012","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"AE Butler","year":"2003","journal-title":"Diabetes"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2009-0543","article-title":"Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I","volume":"150","author":"M B\u00f6ni-Schnetzler","year":"2009","journal-title":"Endocrinology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s001250050029","article-title":"Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women","volume":"43","author":"H Larsson","year":"2000","journal-title":"Diabetologia"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/db08-1158","article-title":"\u03b2- and \u03b1-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance Outcome of a 12-Year Prospective Study in Postmenopausal Caucasian Women","volume":"58","author":"B Ahr\u00e9n","year":"2009","journal-title":"Diabetes"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jtbi.1998.0746","article-title":"Integral Rein Control in Physiology","volume":"194","author":"PT Saunders","year":"1998","journal-title":"Journal of Theoretical Biology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/jtbi.2000.2118","article-title":"Integral Rein Control in Physiology II: a General Model","volume":"206","author":"PT Saunders","year":"2000","journal-title":"Journal of Theoretical Biology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00125-009-1647-6","article-title":"Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance","volume":"53","author":"A Mari","year":"2010","journal-title":"Diabetologia"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00125-011-2112-x","article-title":"Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study","volume":"54","author":"E Ferrannini","year":"2011","journal-title":"Diabetologia"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/db11-1462","article-title":"Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling","volume":"61","author":"AV Matveyenko","year":"2012","journal-title":"Diabetes"},{"key":"ref63","first-page":"5751","article-title":"Clearance and Tissue Distribution of Recombinant Human Interleukin 1\u03b2 in Rats","volume":"50","author":"S Kudo","year":"1990","journal-title":"Cancer Res"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T20:55:00Z","timestamp":1598216100000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003798"}},"subtitle":[],"editor":[{"given":"Martin","family":"Meier-Schellersheim","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1003798","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}